Skip Navigation

GRECO-2: A Randomized, Phase II Study of Stereotactic Body Radiation Therapy SBRT in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04698915

Study #:
STUDY00146896

Start Date:
Nov 17, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04698915

View Complete Trial Details & Eligibility at ClinicalTrials.gov